Literature DB >> 9927162

Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis.

P H Ducluzeau1, A Lachaux, R Bouvier, N Streichenberger, G Stepien, B Mousson.   

Abstract

Few cases of infantile liver disease associated with mitochondrial DNA (mtDNA) depletion have been reported. Most of the patients died before 1 year of age of severe liver failure. We describe a new case, a 28-month-old child, presenting with cholestasis at age 2 months, complicated by progressive portal and lobular liver fibrosis. Growth and psychomotor development are undisturbed. There is no clinical evidence of either myopathy or neurological involvement. Metabolic investigation in plasma revealed an abnormal oxido-reduction status after fasting and after carbohydrate-rich meals. Light microscopy performed on liver biopsies revealed steatosis, abnormal hepatocytes with an "oncocytic" appearance and extensive fibrosis. Electron microscopic investigation showed an increased number of mitochondria with rare or enlarged cristae. Biochemical studies of liver biopsies showed that the respiratory chain activities containing mtDNA-encoded subunits were severely decreased (complexes I, III and IV). In contrast, the complex II activity was normal and the citrate synthase activity was greatly increased. Southern blotting analysis revealed that the ratio of mtDNA to nuclear DNA in liver was only 15% and 20% of the mean control value at ages 12 and 21 months, respectively. For this mtDNA depletion syndrome which is clinically expressed in the liver, a liver transplantation is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927162     DOI: 10.1016/s0168-8278(99)80019-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts.

Authors:  V Procaccio; B Mousson; R Beugnot; H Duborjal; F Feillet; G Putet; I Pignot-Paintrand; A Lombès; R De Coo; H Smeets; J Lunardi; J P Issartel
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.

Authors:  Orly Elpeleg; Chaya Miller; Eli Hershkovitz; Maria Bitner-Glindzicz; Gili Bondi-Rubinstein; Shamima Rahman; Alistair Pagnamenta; Sharon Eshhar; Ann Saada
Journal:  Am J Hum Genet       Date:  2005-04-22       Impact factor: 11.025

Review 3.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  Infantile mitochondrial DNA depletion syndrome associated with methylmalonic aciduria and 3-methylcrotonyl-CoA and propionyl-CoA carboxylase deficiencies in two unrelated patients: a new phenotype of mtDNA depletion syndrome.

Authors:  S Yano; L Li; T P Le; K Moseley; A Guedalia; J Lee; I Gonzalez; R G Boles
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion.

Authors:  Bénédicte Mousson de Camaret; Jan-Willem Taanman; Sylvie Padet; Maïté Chassagne; Martine Mayençon; Pascale Clerc-Renaud; Ginette Mandon; Marie-Thérèse Zabot; Alain Lachaux; Dominique Bozon
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

6.  Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.

Authors:  Reine Note; Caroline Maisonneuve; Philippe Lettéron; Gilles Peytavin; Fatima Djouadi; Anissa Igoudjil; Marie-Christine Guimont; Michel Biour; Dominique Pessayre; Bernard Fromenty
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

7.  Influence of mitochondrial DNA level on cellular energy metabolism: implications for mitochondrial diseases.

Authors:  Christophe Rocher; Jan-Willem Taanman; Denis Pierron; Benjamin Faustin; Giovani Benard; Rodrigue Rossignol; Monique Malgat; Laurence Pedespan; Thierry Letellier
Journal:  J Bioenerg Biomembr       Date:  2008-04-16       Impact factor: 2.945

8.  mtDNA depletion-like syndrome in Wilson disease.

Authors:  Valentina Medici; Gaurav V Sarode; Eleonora Napoli; Gyu-Young Song; Noreene M Shibata; Andre O Guimarães; Charles E Mordaunt; Dorothy A Kieffer; Tagreed A Mazi; Anna Czlonkowska; Tomasz Litwin; Janine M LaSalle; Cecilia Giulivi
Journal:  Liver Int       Date:  2020-09-30       Impact factor: 5.828

9.  Deep Sequencing Reveals Novel Genetic Variants in Children with Acute Liver Failure and Tissue Evidence of Impaired Energy Metabolism.

Authors:  C Alexander Valencia; Xinjian Wang; Jin Wang; Anna Peters; Julia R Simmons; Molly C Moran; Abhinav Mathur; Ammar Husami; Yaping Qian; Rachel Sheridan; Kevin E Bove; David Witte; Taosheng Huang; Alexander G Miethke
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

10.  Mitochondrial DNA depletion and fatal infantile hepatic failure due to mutations in the mitochondrial polymerase γ (POLG) gene: a combined morphological/enzyme histochemical and immunocytochemical/biochemical and molecular genetic study.

Authors:  J Müller-Höcker; R Horvath; S Schäfer; H Hessel; W Müller-Felber; J Kühr; W C Copeland; P Seibel
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.